Cell hypertrophy and MEK/ERK phosphorylation are regulated by glyceraldehyde-derived AGEs in cardiomyocyte H9c2 cells (Q39216600)

10 September 2017

Cell hypertrophy and MEK/ERK phosphorylation are regulated by glyceraldehyde-derived AGEs in cardiomyocyte H9c2 cells (English)

1 reference

10 September 2017

0 references

Shun-Yao Ko

1

1 reference

10 September 2017

I-Hsuan Lin

2

1 reference

10 September 2017

Tzong-Ming Shieh

3

1 reference

10 September 2017

Hsin-An Ko

4

1 reference

10 September 2017

Hong-I Chen

5

1 reference

10 September 2017

Tzong-Cherng Chi

6

1 reference

10 September 2017

Shu-Shing Chang

7

1 reference

10 September 2017

Yi-Chiang Hsu

8

1 reference

10 September 2017

1 July 2013

1 reference

Cell Biochemistry and Biophysics

10 September 2017

1 reference

10 September 2017

66

1 reference

10 September 2017

3

1 reference

10 September 2017

537-544

1 reference

https://scigraph.springernature.com/pub.10.1007/s12013-012-9501-8

10 September 2017

0 references

cites work

TAGE (toxic AGEs) theory in diabetic complications

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Role of the Maillard reaction in diabetes mellitus and diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Rutin from Lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

S100B's double life: intracellular regulator and extracellular signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Glycolaldehyde induces oxidative stress in the heart: a clue to diabetic cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9501-8

10.1007/S12013-012-9501-8

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference